U.S. Naloxone Market, By Drug Type (Branded and Generic), By Route of Administration (Intranasal Administration, Intramuscular Administration, Intravenous Administration, and others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Published In : Aug 2024

Code : CMI4953

Pages :198

Formats :

Excel and PDF

Industry : Pharmaceutical

Key Developments

In May 2024,Walgreens launched its own Naloxone HCI Nasal Spray at $34.99, which is cheaper than the national brand. The product, available online now and in all stores by the end of the month, helps reverse opioid overdoses and will be located in the pain aisle, enhancing access for the millions of customers and patients served daily.
In May 2024,Amneal Pharmaceuticals started supplying its OTC Naloxone HCI Nasal Spray, 4mg, to U.S. retail pharmacies and California. Approved by the FDA in April 2024, this generic version of NARCAN HCI Nasal Spray will be distributed through the CalRx Naloxone Access Initiative.
In April 2024, Amneal Pharmaceuticals has launched an Over-the-Counter (OTC) Naloxone Hydrochloride Nasal Spray, 4mg, following FDA approval. This generic version of NARCAN HCI Nasal Spray is designed to treat opioid overdoses.
In August 2023, Emergent BioSolutions Inc. announced that NARCAN Naloxone HCl Nasal Spray 4 mg will be available nationwide and online starting in September. This Over-the-Counter (OTC) access enhances the ability to respond to opioid emergencies, potentially saving lives as synthetic opioids, like fentanyl, continue to drive the crisis.